agilon health (NYSE:AGL) Shares Gap Down – Time to Sell?

agilon health, inc. (NYSE:AGLGet Free Report)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $2.26, but opened at $2.19. agilon health shares last traded at $2.13, with a volume of 99,490 shares trading hands.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on AGL. TD Cowen cut their target price on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Stifel Nicolaus reduced their target price on agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research note on Tuesday, November 12th. Benchmark restated a “buy” rating and issued a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Evercore ISI reduced their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Finally, Citigroup lowered their price objective on agilon health from $2.50 to $1.75 and set a “sell” rating for the company in a research report on Wednesday, November 13th. Three investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $6.05.

Check Out Our Latest Stock Analysis on agilon health

agilon health Stock Performance

The company has a fifty day moving average of $2.83 and a two-hundred day moving average of $4.70. The stock has a market capitalization of $869.36 million, a P/E ratio of -2.24 and a beta of 0.60. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

agilon health (NYSE:AGLGet Free Report) last posted its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period in the previous year, the firm earned ($0.06) earnings per share. On average, equities analysts anticipate that agilon health, inc. will post -0.47 EPS for the current year.

Insiders Place Their Bets

In other agilon health news, CEO Steven Sell acquired 20,000 shares of agilon health stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average price of $3.36 per share, with a total value of $67,200.00. Following the purchase, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. This trade represents a 42.03 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

Several large investors have recently made changes to their positions in the business. Virtu Financial LLC acquired a new stake in agilon health during the third quarter valued at approximately $120,000. Geode Capital Management LLC increased its stake in shares of agilon health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after buying an additional 84,889 shares during the period. Barclays PLC raised its position in shares of agilon health by 21.2% during the third quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock worth $4,830,000 after acquiring an additional 214,830 shares during the last quarter. XTX Topco Ltd lifted its stake in shares of agilon health by 271.1% during the third quarter. XTX Topco Ltd now owns 119,747 shares of the company’s stock valued at $471,000 after acquiring an additional 87,481 shares during the period. Finally, State Street Corp boosted its holdings in agilon health by 3.0% in the third quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after acquiring an additional 215,733 shares during the last quarter.

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Stories

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.